Live Markets
Saturday, September 12, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

KZR (KZR)

Biotechnology

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
P/E (TTM)
EPS
Div Yield
52W Range
Beta

Company overview

Live quote temporarily unavailable — press releases and news are still shown below.

No company overview is available for KZR yet.

Peers in Biotechnology

All in industry →

Recent press releases

March 2026

5 months ago8-KHealthcare

Kezar Life Sciences, Inc. — 8-K Filing

KZRKezar Life Sciences, Inc.

# 🧾 What This Document Is This is an **SEC Form 8-K filing** from Kezar Life Sciences. It contains the official legal contracts for a major corporate event: **Kezar is being acquired by Aurinia Pharma.** Think of it like the final paperwork you sign when selling a house. It doesn't just say "we'r

Read summaryView on SEC EDGAR

SEC filings

All filings →
1 recent filing shown in the timeline above. View all SEC filings →

KZR has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-09-30 · prior 2025-06-30
157,286 sh● NEW

People at KZR

All people →

Quarterly financials

Full financials →
Revenue trend
03/25
NI -$16.6M
06/25
NI -$13.7M
09/25
NI -$11.2M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $-1.53
Prior: $-1.87
Revenue sparkline